Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Non Operating Investment Income (2022 - 2025)

Treace Medical Concepts' Non Operating Investment Income history spans 4 years, with the latest figure at -$11000.0 for Q4 2025.

  • For Q4 2025, Non Operating Investment Income rose 88.3% year-over-year to -$11000.0; the TTM value through Dec 2025 reached -$25000.0, up 62.12%, while the annual FY2025 figure was -$25000.0, 62.12% up from the prior year.
  • Non Operating Investment Income reached -$11000.0 in Q4 2025 per TMCI's latest filing, down from $33000.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $311000.0 in Q4 2023 to a low of -$163000.0 in Q2 2023.
  • Average Non Operating Investment Income over 4 years is $5538.5, with a median of -$27000.0 recorded in 2022.
  • Peak YoY movement for Non Operating Investment Income: skyrocketed 1251.85% in 2023, then plummeted 224.14% in 2024.
  • A 4-year view of Non Operating Investment Income shows it stood at -$27000.0 in 2022, then surged by 1251.85% to $311000.0 in 2023, then tumbled by 130.23% to -$94000.0 in 2024, then skyrocketed by 88.3% to -$11000.0 in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Non Operating Investment Income are -$11000.0 (Q4 2025), $33000.0 (Q3 2025), and -$7000.0 (Q2 2025).